Literature DB >> 14677167

The gut in ankylosing spondylitis and other spondyloarthropathies: inflammation beneath the surface.

Filip De Keyser, Herman Mielants.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14677167

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  NSAID-induced deleterious effects on the proximal and mid small bowel in seronegative spondyloarthropathy patients.

Authors:  Mihai Rimbaş; Mădălina Marinescu; Mihail Radu Voiosu; Cristian Răsvan Băicuş; Simona Caraiola; Adriana Nicolau; Doina Niţescu; Georgeta Camelia Badea; Magda Ileana Pârvu
Journal:  World J Gastroenterol       Date:  2011-02-28       Impact factor: 5.742

2.  Anti-Saccharomyces cerevisiae (ASCA) and anti-endomysial antibodies in spondyloarthritis.

Authors:  Marianne A Andretta; Thaís D Vieira; Renato Nishiara; Thelma L Skare
Journal:  Rheumatol Int       Date:  2011-02-09       Impact factor: 2.631

Review 3.  Taiwan Rheumatology Association consensus recommendations for the management of axial spondyloarthritis.

Authors:  James Cheng-Chung Wei; Chin-Hsiu Liu; Jui-Cheng Tseng; Lin-Fen Hsieh; Chun-Hsiung Chen; Hsin-Hua Chen; Hung-An Chen; Ying-Chou Chen; Chung-Tei Chou; Hsien-Tzung Liao; Yi-Chun Lin; Shue-Fen Luo; Deng-Ho Yang; Kai-Jieh Yeo; Wen-Chan Tsai
Journal:  Int J Rheum Dis       Date:  2019-11-27       Impact factor: 2.454
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.